COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,804 Articles (22,527 medRxiv, 8,277 bioRxiv)

Most recent first Previous |  Page 2323: Articles 23221-23230  | Next

Worldwide tracing of mutations and the evolutionary dynamics of SARS-CoV-2
Zhou, Z.-Y., Liu, H., Zhang, Y.-D., Wu, Y.-Q., Peng, M.-S., Li, A., Irwin, D. M., Li, H., Lu, J., Bao, Y., Lu, X., Liu, D., Zhang, Y.-P.
10.1101/2020.08.07.242263 — Posted: 2020-08-12
Love during lockdown: findings from an online survey examining the impact of COVID-19 on the sexual practices of people living in Australia
Coombe, J., Kong, F., Bittleston, H., Williams, H., Tomnay, J., Vaisey, A., Malta, S., Goller, J., Temple-Smith, M., Bourchier, L., Lau, A., Chow, E., Hocking, J. S.
10.1101/2020.08.10.20171348 — Posted: 2020-08-12
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposition to adults with COVID-19: preliminary findings
buonsenso, d., Valentini, P., De Rose, C., Pata, D., Sinatti, D., Speziale, D., Ricci, R., Carfi, A., Landi, F., Sanguinetti, M., Sali, M.
10.1101/2020.08.10.20169912 — Posted: 2020-08-12
Histopathology of Third Trimester Placenta from SARS-CoV-2-Positive Women
He, M., Skaria, P., Kreutz, K., Chen, L., Hagemann, I., Carter, E. B., Mysorekar, I. U., Nelson, D. M., Pfeifer, J., Dehner, L. P.
10.1101/2020.08.11.20173005 — Posted: 2020-08-12 Discussion: Offsite
High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2: a nationwide household survey
Menezes, A. M. B., Victora, C. G., Hartwig, F. P., Silveira, M. F., Horta, B. L., Barros, A. J. D., Whermeister, F. C., Mesenburg, M. A., Pellanda, L. C., Dellagostin, O. A., Struchiner, C. J., Burattini, M. N., Barros, F. C., Hallal, P. C.
10.1101/2020.08.10.20171942 — Posted: 2020-08-12
Stochastic extinction of epidemics: how long does would it take for Sars-Cov-2 to die out?
Khatri, B. S.
10.1101/2020.08.10.20171454 — Posted: 2020-08-12
Extended SEIQR type model for COVID-19 epidemic and data analysis
Sharma, S., Volpert, V., Banerjee, M.
10.1101/2020.08.10.20171439 — Posted: 2020-08-12
Impaired cellular immunity to SARS-CoV-2 in severe COVID-19 patients
Ni, L., Cheng, M.-L., Zhao, H., Feng, Y., Liu, J., Ye, F., Ye, Q., Zhu, G., Li, X., Wang, P., Shao, J., Deng, Y.-q., Wei, P., Chen, F., Qin, C.-f., Wang, G., Li, F., Zeng, H., Dong, C.
10.1101/2020.08.10.20171371 — Posted: 2020-08-12
Improved COVID-19 testing by extraction free SARS-Cov-2 RT-PCR
mokhtar, k. m.
10.1101/2020.08.10.20171512 — Posted: 2020-08-12
On the track of the D839Y mutation in the SARS-CoV-2 Spike fusion peptide: emergence and geotemporal spread of a highly prevalent variant in Portugal
Borges, V., Isidro, J., Cortes-Martins, H., Duarte, S., Vieira, L., Leite, R., Gordo, I., Caetano, C. P., Nunes, B., Sa, R., Oliveira, A., Guiomar, R., Gomes, J. P., Portuguese network for SARS-CoV-2 genomics
10.1101/2020.08.10.20171884 — Posted: 2020-08-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).